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The Editorial introducing the August 2012 issue of this
Journal contained a critical review of the Grossman model
(MGM henceforth). The Reply by Robert Kaestner in this
issue starts with an impressive list of his preventive efforts
ranging from jogging to having a rectal exam. All very
well, but does this mean that his behavior is always guided
by the kind of long-term planning that underlies the MGM?
Criticism of the MGM can be summed up in one simple,
humble statement of the man in the street, ‘‘When I’m sick,
I need to see the doctor’’.
In economic language, this is a statement about the
elasticity of substitution (EOS). It claims the EOS to be
(close) to zero in the sick state. This implies that the mix of
inputs is dominated by medical care rather than one’s own
preventive effort regardless of the price of medical care
relative to (mainly) one’s own opportunity cost of time.
The lay person’s statement is silent about the EOS in the
healthy state; presumably, it does not exclude a nonzero
value. If so, it implies state-dependence of the EOS.
Robert Kaestner’s examples designed to support the
MGM would be more convincing if he were to claim that
when falling ill, he would continue to combine inputs to the
production of health in the same way as at present (actu-
ally, according to the MGM he should even make more
effort of his own since illness presumably lowers the
opportunity cost of his time while leaving the price of
medical care unchanged). Also, total investment in health
should decrease at least in the case of a serious illness when
time to death suddenly becomes short, reducing the present
value of returns to investment. Neither prediction is borne
out by the data.
First, there is a tradition of research that focuses on
health care expenditure (HCE) in isolation (see, e.g.,
Manning et al. [2]). Yet according to the MGM with its
state-independent EOS, a two-factor model that simulta-
neously explains own effort and HCE should always be
specified. Moreover, using cross section data, no more than
about 20 % of the variance in HCE can be explained using
observable personal characteristics, environmental factors,
and insurance information. The coefficient of determina-
tion increases to about 50 % if lagged HCE is included in
the regression, but that means specifying a stochastic
process—exactly the alternative sketched towards the end
of the Editorial. Finally, much of the effort directed at
empirically estimating HCE has been directed to its sto-
chastic component using generalized linear models. This
calls for adding a non-normal error term to the systematic,
non-stochastic part of the regression equation. Usually, the
Gamma distribution is found to fit best because it can
accommodate the heavy skewness characterizing the dis-
tribution of HCE. Note that, conceptually, the MGM seeks
to explain total HCE as measured. However, outliers in
HCE of the observed magnitudes do not sit well with an
investment process that involves own effort and HCE
regardless of the health state the individual is in. Of course,
Robert Kaestner is free to disqualify the results of the
research cited above as being the outcome of ‘questionable
research design’ (quote from his Reply).
Second, as to the influence of time to death, there is a
considerable body of evidence suggesting that it is the main
driver of HCE. In fact, HCE is found to just about explode
towards the end of life even when the endogeneity of
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longevity with regard to HCE is controlled for [1]. Of
course, Robert Kaestner is again free to dismiss this
research as reflecting ‘questionable research design’. Yet it
may be noted that longevity amounts to nothing but the
convolution (multiplication in the unlikely case of inde-
pendence) of short-term survival probabilities. Therefore,
the evidence cited by him linking preventive effort to
longevity may very well be the outcome of sequential
short-term optimization seeking to achieve a target value of
the probability to be in good health (in the limit, to sur-
vive). As sketched in the Editorial, this stochastic formu-
lation emphasizing the short run also predicts adjustment
behavior. In the healthy state, the probability of being
healthy turns out to be equal to one ex post, (slightly)
above target—contrary to the MGM which disallows an
‘overshooting’ of the desired health stock. The natural way
to adjust is to (slightly) cut down on preventive effort. In
the sick state, this probability turns out to be zero, way
below target for most. The natural adjustment is to use a lot
of HCE in order to get back to the desired probability of
being healthy. Sounds familiar?
Also, having learned from the MGM that HCE consti-
tutes a long-run investment in health, just about any lay
person would predict that the closer one believes to be to
death, the shorter the estimated payback period and the
weaker the incentive to invest by spending on HCE. As
shown above, the data tell otherwise. However, when the
individual considered is described as still seeing a possi-
bility to attain his or her desired probability of being
healthy tomorrow (of surviving in the limit), the same
person likely would modify his or her prediction in favor of
substantial spending on HCE.
On a final note, Robert Kaestner manages to disqualify
the Editorial ten times on no more than two pages, using
expressions ranging from ‘flawed’ to ‘glaring weakness’.
This aggressive style is reminiscent of a cleric who seeks to
defend the Absolute Truth against a heretic. Scientific
debate, at least in the view of this writer, revolves around
consistency in theorizing and, most importantly, empirical
evidence. Towards the end of his Reply, Robert Kaestner
does offer a formulation designed to shore up the MGM.
Unfortunately, it is of the same capital-adjustment type that
was specified by Wagstaff [3] but rejected by the data as
shown in the Editorial. Once more, that finding can be
qualified as being the outcome of ‘questionable research
design’. Conversely, the common man’s perception
invoked here of course does not constitute systematic
empirical evidence. Yet economic theorizing that is seri-
ously at odds with the common man’s view is unlikely to
stand the test of time. Up to the readers of this Journal to
judge …
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